Tyra Biosciences Stock Investor Sentiment
| TYRA Stock | USD 12.14 0.06 0.49% |
About 68% of Tyra Biosciences' investor base is looking to short. The analysis of the overall investor sentiment regarding Tyra Biosciences suggests that many traders are alarmed. The current market sentiment, together with Tyra Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Tyra Biosciences stock news signals to limit their universe of possible portfolio assets.
Tyra |
Tyra Biosciences Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Tyra Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Tyra Biosciences that are available to investors today. That information is available publicly through Tyra media outlets and privately through word of mouth or via Tyra internal channels. However, regardless of the origin, that massive amount of Tyra data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Tyra Biosciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Tyra Biosciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Tyra Biosciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Tyra Biosciences alpha.
Tyra Biosciences Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Disposition of tradable shares by Moran Susan of Tyra Biosciences subject to Rule 16b-3 | 12/17/2024 |
2 | Tyra Biosciences, Inc. Receives Consensus Recommendation of Buy from Analysts - MarketBeat | 01/07/2025 |
3 | Disposition of 835 shares by Kjellson Nina S of Tyra Biosciences at 16.287 subject to Rule 16b-3 | 01/16/2025 |
4 | Disposition of 93 shares by Kjellson Nina S of Tyra Biosciences at 16.3626 subject to Rule 16b-3 | 01/21/2025 |
5 | Tyra Biosciences Announces Poster Presentations at 2025 ASCO Gastrointestinal Cancers Symposium - PR Newswire | 01/22/2025 |
6 | Disposition of 4825 shares by Kjellson Nina S of Tyra Biosciences at 16.2624 subject to Rule 16b-3 | 01/23/2025 |
7 | Private equity firms account for 44 percent of Tyra Biosciences, Inc.s ownership, while institutions account for 33 | 01/27/2025 |
8 | Tyra Biosciences Insider Ups Holding By 284 percent During Year - Simply Wall St | 01/30/2025 |
9 | Disposition of 3511 shares by Kjellson Nina S of Tyra Biosciences at 13.7611 subject to Rule 16b-3 | 02/05/2025 |
10 | Tyra Biosciences Hits New 52-Week Low - Should You Sell - MarketBeat | 02/07/2025 |
11 | Tyra Biosciences Hits New 52-Week Low Heres Why | 02/12/2025 |
12 | Investment Analysis - Stock Traders Daily | 02/19/2025 |
Complementary Tools for Tyra Stock analysis
When running Tyra Biosciences' price analysis, check to measure Tyra Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tyra Biosciences is operating at the current time. Most of Tyra Biosciences' value examination focuses on studying past and present price action to predict the probability of Tyra Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tyra Biosciences' price. Additionally, you may evaluate how the addition of Tyra Biosciences to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |